• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 231/14 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 231/14

Total number of patents in this class: 1156

10-year publication summary

71
93
79
71
76
79
66
54
48
39
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bayer Cropscience AG
1830
56
BASF SE
21320
34
Syngenta Participations AG
1479
34
Syngenta Crop Protection AG
6756
32
BioCryst Pharmaceuticals, Inc.
185
32
Theravance Biopharma R&D IP, LLC
359
27
Eonhf, Inc.
45
21
Orion Corporation
785
19
Takeda Pharmaceutical Company Limited
2700
18
Sumitomo Chemical Company, Limited
8965
15
Activesite Pharmaceuticals, Inc.
17
14
Loxo Oncology, Inc.
84
12
Solvay SA
945
12
Syngenta Limited
422
11
Dow AgroSciences LLC
1179
11
Research Triangle Institute
419
11
sanofi-aventis
286
11
Hoffmann-La Roche Inc.
3841
10
AstraZeneca AB
2823
10
Bayer Intellectual Property GmbH
2351
10
Other owners 756